110 related articles for article (PubMed ID: 34982495)
21. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
Tadić V; Josipović G; Zoldoš V; Vojta A
Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
[TBL] [Abstract][Full Text] [Related]
22. Orthogonal Demethylase-Activated Deoxyribozyme for Intracellular Imaging and Gene Regulation.
Wang Q; Tan K; Wang H; Shang J; Wan Y; Liu X; Weng X; Wang F
J Am Chem Soc; 2021 May; 143(18):6895-6904. PubMed ID: 33905655
[TBL] [Abstract][Full Text] [Related]
23. A Self-Catabolic Multifunctional DNAzyme Nanosponge for Programmable Drug Delivery and Efficient Gene Silencing.
Wang J; Yu S; Wu Q; Gong X; He S; Shang J; Liu X; Wang F
Angew Chem Int Ed Engl; 2021 May; 60(19):10766-10774. PubMed ID: 33599385
[TBL] [Abstract][Full Text] [Related]
24. Cationic Polymer-Mediated CRISPR/Cas9 Plasmid Delivery for Genome Editing.
Zhang Z; Wan T; Chen Y; Chen Y; Sun H; Cao T; Songyang Z; Tang G; Wu C; Ping Y; Xu FJ; Huang J
Macromol Rapid Commun; 2019 Mar; 40(5):e1800068. PubMed ID: 29708298
[TBL] [Abstract][Full Text] [Related]
25. A non-cationic nucleic acid nanogel for the delivery of the CRISPR/Cas9 gene editing tool.
Ding F; Huang X; Gao X; Xie M; Pan G; Li Q; Song J; Zhu X; Zhang C
Nanoscale; 2019 Oct; 11(37):17211-17215. PubMed ID: 31531437
[TBL] [Abstract][Full Text] [Related]
26. A Genome-Editing Nanomachine Constructed with a Clustered Regularly Interspaced Short Palindromic Repeats System and Activated by Near-Infrared Illumination.
Peng H; Le C; Wu J; Li XF; Zhang H; Le XC
ACS Nano; 2020 Mar; 14(3):2817-2826. PubMed ID: 32048826
[TBL] [Abstract][Full Text] [Related]
27. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
[TBL] [Abstract][Full Text] [Related]
28. A cascade signal amplification strategy for surface enhanced Raman spectroscopy detection of thrombin based on DNAzyme assistant DNA recycling and rolling circle amplification.
Gao F; Du L; Tang D; Lu Y; Zhang Y; Zhang L
Biosens Bioelectron; 2015 Apr; 66():423-30. PubMed ID: 25497982
[TBL] [Abstract][Full Text] [Related]
29. Spatiotemporal Delivery of CRISPR/Cas9 Genome Editing Machinery Using Stimuli-Responsive Vehicles.
Cai W; Luo T; Mao L; Wang M
Angew Chem Int Ed Engl; 2021 Apr; 60(16):8596-8606. PubMed ID: 32385892
[TBL] [Abstract][Full Text] [Related]
30. Co-delivery of Sorafenib and CRISPR/Cas9 Based on Targeted Core-Shell Hollow Mesoporous Organosilica Nanoparticles for Synergistic HCC Therapy.
Zhang BC; Luo BY; Zou JJ; Wu PY; Jiang JL; Le JQ; Zhao RR; Chen L; Shao JW
ACS Appl Mater Interfaces; 2020 Dec; 12(51):57362-57372. PubMed ID: 33301289
[TBL] [Abstract][Full Text] [Related]
31. Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment.
Xu X; Liu C; Wang Y; Koivisto O; Zhou J; Shu Y; Zhang H
Adv Drug Deliv Rev; 2021 Sep; 176():113891. PubMed ID: 34324887
[TBL] [Abstract][Full Text] [Related]
32. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
[TBL] [Abstract][Full Text] [Related]
33. Smart Catalyzed Hairpin Assembly-Induced DNAzyme Nanosystem for Intracellular UDG Imaging.
Song X; Ding Q; Zhang J; Sun R; Yin L; Wei W; Pu Y; Liu S
Anal Chem; 2021 Oct; 93(40):13687-13693. PubMed ID: 34583508
[TBL] [Abstract][Full Text] [Related]
34. Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications.
Liu C; Zhang L; Liu H; Cheng K
J Control Release; 2017 Nov; 266():17-26. PubMed ID: 28911805
[TBL] [Abstract][Full Text] [Related]
35. The CRISPR/Cas9 system and its applications in crop genome editing.
Bao A; Burritt DJ; Chen H; Zhou X; Cao D; Tran LP
Crit Rev Biotechnol; 2019 May; 39(3):321-336. PubMed ID: 30646772
[TBL] [Abstract][Full Text] [Related]
36. New Insights into the Therapeutic Applications of CRISPR/Cas9 Genome Editing in Breast Cancer.
Ahmed M; Daoud GH; Mohamed A; Harati R
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34066014
[TBL] [Abstract][Full Text] [Related]
37. CRISPR/Cas9-mediated genome editing in sea urchins.
Lin CY; Oulhen N; Wessel G; Su YH
Methods Cell Biol; 2019; 151():305-321. PubMed ID: 30948015
[TBL] [Abstract][Full Text] [Related]
38. Carboxylated nanodiamond-mediated CRISPR-Cas9 delivery of human retinoschisis mutation into human iPSCs and mouse retina.
Yang TC; Chang CY; Yarmishyn AA; Mao YS; Yang YP; Wang ML; Hsu CC; Yang HY; Hwang DK; Chen SJ; Tsai ML; Lai YH; Tzeng Y; Chang CC; Chiou SH
Acta Biomater; 2020 Jan; 101():484-494. PubMed ID: 31672582
[TBL] [Abstract][Full Text] [Related]
39. A Cloning-Free Method for CRISPR/Cas9-Mediated Genome Editing in Fission Yeast.
Zhang XR; He JB; Wang YZ; Du LL
G3 (Bethesda); 2018 May; 8(6):2067-2077. PubMed ID: 29703785
[TBL] [Abstract][Full Text] [Related]
40. mRNA-Activated Multifunctional DNAzyme Nanotweezer for Intracellular mRNA Sensing and Gene Therapy.
He M; He M; Nie C; Yi J; Zhang J; Chen T; Chu X
ACS Appl Mater Interfaces; 2021 Feb; 13(7):8015-8025. PubMed ID: 33561348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
